Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesNerve Conduction TestsCPT cpt-95911-nerve-conduction-studies-9-10-studies
    Ask Trek AI about this page

    CPT 95911: Nerve Conduction Studies, 9–10 Tests

    Medicare pays $152 and commercial payers pay $256 on average nationally for this procedure.

    CPT code 95911 describes a diagnostic nerve conduction study procedure involving nine to ten nerve conduction studies to evaluate motor and sensory nerve electrical conduction; the service is a neurodiagnostic test typically performed in an ambulatory clinic or outpatient neurodiagnostic lab setting to assess peripheral nerve function for conditions such as entrapment neuropathies.

    For related coverage guidance, see recent payer policy updates: Navigated Transcranial Magnetic Stimulation for Preoperative Brain Mapping, Navigated Transcranial Magnetic Stimulation for Preoperative Brain Mapping, Navigated Transcranial Magnetic Stimulation for Preoperative Brain Mapping.

    Customize your policy alerts

    Sign up for cpt 95911 policy alerts

    Get alerted when payer policies referencing 95911 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    Commercial averages sit well above Medicare: Blue Cross Blue Shield, Cigna, Aetna, UnitedHealth Group and BUCA all have mean commercial rates notably higher than Medicare’s mean of $152.20; BUCA’s mean of $256.00 in particular is roughly $103.80 above Medicare, highlighting a wide gulf between Medicare payment levels and commercial average contracting for CPT 95911. Dispersion across payers varies: range (P75–P25) calculations show Blue Cross Blue Shield at $97.70, UnitedHealth Group at $162.30, Cigna at $163.60, Aetna at $132.00, and BUCA at $121.90. Cigna and UnitedHealth Group display the widest interquartile spreads (~$163), indicating greater variability in commercial reimbursed rates, while Blue Cross Blue Shield is the tightest at $97.70, suggesting comparatively concentrated commercial pricing.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A 48-year-old office worker presents with progressive numbness, tingling, and intermittent nocturnal hand pain in both hands, worse on the right. Physical exam demonstrates positive Tinel and Phalen signs over the carpal tunnels and thenar muscle weakness on the right. The neurologist schedules nerve conduction studies to evaluate median and ulnar nerve function and to quantify severity of focal demyelination/axonal loss. The typical clinical workflow: patient check-in and consent; focused history and focused physical exam; preparation of skin and placement of surface recording and stimulating electrodes; performance of 9–10 nerve conduction studies (motor and sensory studies of median, ulnar, and possibly radial nerves, with comparative or segmental techniques as indicated); optional limited needle electromyography if clinically warranted (separately reported); immediate review of tracings by the performing clinician; documentation of study findings, technical parameters, interpretation, and impression (for example, right greater-than-left median neuropathy at the wrist consistent with carpal tunnel syndrome). Results are provided to the referring clinician and incorporated into treatment planning such as splinting, corticosteroid injection, or referral for surgical consultation.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    95910Nerve conduction studies; 7–8 studiesRepresents a smaller battery of nerve conduction studies often used when fewer nerves or segments are tested; adjacent code for fewer studies.

    Related Modifiers

    6 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    25CPT modifier 25 indicates that on the same day as another procedure or service, the same physician or other qualified health care professional provided a significant, separately identifiable…- When to apply: Use modifier 25 only on an E/M code to indicate the same provider delivered a significant, separately identifiable E/M service on the same day as another procedure or service — i.e.,…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    50Modifier –50 (Bilateral Procedure) is appended to a CPT code when an identical procedure is performed on paired anatomical structures during the same operative session. The AMA states to add…- Use modifier -50 when the same CPT surgical, diagnostic, or radiology procedure is performed on paired anatomical structures (both sides of the body) during the same operative/session by the same…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    2084N0400X
    208200000X
    2278P1004X
    246XC2901X
    246ZE0500X
    2278G1100X
    251K00000X
    246QC1000X

    Related ICD-10-CM Codes

    20 rows

    ICD-10-CM CodeDescription
    E10.42Type 1 diabetes mellitus with diabetic polyneuropathy
    E11.42Type 2 diabetes mellitus with diabetic polyneuropathy
    F45.41Pain disorder exclusively related to psychological factors
    G56.01Carpal tunnel syndrome, right upper limb
    G56.02Carpal tunnel syndrome, left upper limb
    G60.0Hereditary motor and sensory neuropathy
    G60.9Hereditary and idiopathic neuropathy, unspecified
    G62.9Polyneuropathy, unspecified
    G63Polyneuropathy in diseases classified elsewhere
    G64Other disorders of peripheral nervous system

    Showing 1–10 of 20

    Related Payer Policy Updates

    Specialty: Neurology/Neurosurgery1 / 2

    10 rows

    PolicyPayerEffective Date
    Navigated Transcranial Magnetic Stimulation for Preoperative Brain Mappingpremerabluecrossofwashington2027-02-05
    Navigated Transcranial Magnetic Stimulation for Preoperative Brain Mappingpremerabluecrossofwashington2027-02-05
    Navigated Transcranial Magnetic Stimulation for Preoperative Brain Mappingpremerabluecrossofwashington2027-02-05
    Multiple Sclerosis Products: Ocrevus, Ocrevus Zunovo, and Briumviblue cross blue shield - tennessee2027-01-30
    Calcitonin Gene-Related Peptide (CGRP) Inhibitors: Vyepti (eptinezumab-jjmr)Mass General Brigham Health Plan2027-01-04
    Clinical Review Criteria Intraoperative Neurophysiological Monitoring (IONM)Kaiser Permanente2027-01-01
    Multiple Sclerosis Products: Ocrevus, Ocrevus Zunovo, and Briumviblue cross blue shield - tennessee2026-12-31
    Open Neuroplasty Lumbar PlexusCigna2026-12-15
    Laser Interstitial Thermal TherapyCigna2026-11-15
    Laser Interstitial Thermal TherapyCigna2026-11-15

    Related Codes

    CPT-95905-NERVE-CONDUCTION-STUDIES-MOTOR-SENSORY

    CPT 95905: Motor and Sensory Nerve Conduction Study

    CPT-95907-NERVE-CONDUCTION-STUDY-1-2-NERVES

    CPT 95907: Nerve Conduction Study, One or Two Nerves

    CPT-95908-NERVE-CONDUCTION-STUDY-THREE-TO-FOUR-STUDIES

    CPT 95908: Three to Four Nerve Conduction Studies

    CPT-95909-NERVE-CONDUCTION-STUDY-FIVE-SIX-STUDIES

    CPT 95909: Nerve Conduction Studies, Five to Six

    CPT-95910-SEVEN-TO-EIGHT-NERVE-CONDUCTION-STUDIES

    CPT 95910: Nerve Conduction Studies, Seven to Eight Studies

    CPT-95912-NERVE-CONDUCTION-STUDIES-11-12

    CPT 95912: Nerve Conduction Studies, 11–12 Tests

    CPT-95913-NERVE-CONDUCTION-STUDIES-13-OR-MORE

    CPT 95913: Nerve Conduction Studies, 13+ Tests

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    95912Nerve conduction studies; 11–12 studiesRepresents a larger battery when more nerves or additional segments are tested; adjacent code for more extensive testing.